Recent Updates
Recently added Catalysts
RIGL Positive Sentiment

Rigel Announces Conference Call and Webcast to Report Second Quarter 2024 Financial Results and Business Update

Tuesday, July 30, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Rigel Pharmaceuticals, Inc. announced that it will release its second quarter financial results on August 6, 2024. Following the results, the company will host a live conference call and webcast at 4:30 p.m. ET to discuss the outcomes and provide a business update. Participants can join the call either via telephone or through the company's website, where the session will also be archived for later viewing.
Price reaction · baseline $10.61 (2024-07-29 close) · hit after-hours · clean, no other RIGL news in the window
day 0 close
+0.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Rigel will report its financial results, indicating ongoing business activity.
  • The live conference call allows investors to engage directly with management.
  • The webcast will provide updates on both financial results and business operations.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+9%
120-day peak, hindsight
Typical move
12.1%
average across 2 past catalysts
Lead asset
Fostamatinib
Phase 2 · Acute Respiratory Distress Syndrome

Full Press Release Details

SOUTH SAN FRANCISCO, Calif., July 30, 2024 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its second quarter 2024 financial results after market close on Tuesday, August 6, 2024. Rigel senior management will follow the announcement with a live conference call and webcast at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss the financial results and give an update on the business.
Participants can access the live conference call by dialing 877-407-3088 (domestic) or 201-389-0927 (international). The conference call and accompanying slides will also be webcast live and can be accessed from the Investor Relations section of the company's website at www.rigel.com. The webcast will be archived and available for replay for 90 days after the call via the Rigel website.
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com.
Contact for Investors & Media:
Rigel Pharmaceuticals, Inc.
Email: [email protected]

Frequently Asked Questions

When will Rigel report its Q2 2024 financial results?

Rigel will report its Q2 2024 financial results on August 6, 2024.

What time is the conference call to discuss financial results?

The conference call will take place at 4:30 p.m. Eastern Time.

How can I access the live conference call?

Participants can call 877-407-3088 (domestic) or 201-389-0927 (international).

Will the conference call be available for replay?

Yes, the webcast will be available for replay for 90 days after the call.

What does Rigel Pharmaceuticals specialize in?

Rigel specializes in novel therapies for hematologic disorders and cancer.

ShareAdd on Google
Tags: RIGL Viatris Investor Conferences Healthcare Rigel Pharmaceuticals financial results conference call Q2 2024 biotechnology
Last updated: Jul 30, 2024

Biotech snapshot

Cash runway
$95M liquidity · $0M/mo burn
Low dilution risk
Lead asset
FostamatinibPhase 2
Acute Respiratory Distress Syndrome →

Catalyst track record

+9%
best trade around RIGL's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for RIGL.

See every catalyst's timing & PoA →